Oncotype DX? Breast Cancer Test Predicts Late Recurrence Five to 15 Years Out
There are 1 comment on the Applied Clinical Trials story from May 29, 2014, titled Oncotype DX? Breast Cancer Test Predicts Late Recurrence Five to 15 Years Out. In it, Applied Clinical Trials reports that:
New Data Presented at ASCO Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to Benefit from Extended Hormonal Therapy New Data Presented at ASCO Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to ... (more)
Join the discussion below, or Read more at Applied Clinical Trials.
#1 May 29, 2014
Why waste peoples time with a test that predicts a RECURRENCE? Solve the damn puzzle and find the cure you idiots. Your record thus far sucks. You've been at it for 80 years and still women are dying while you spend billions on RESEARCH.
Add your comments below
|After Baltz Firing, CARTI Issues Statement||14 hr||Regina C||8|
|Alarming Facts About African American Women and... (Oct '15)||Mar '18||mike||7|
|Estate of Geneva Adams by and Through Her Perso...||Mar '18||is this it||3|
|5 simple habits that can reduce your risk of br...||Feb '18||Climb every mountain||1|
|Autistic twins from Fitchburg will be losing th...||Jan '18||Feel good story||1|
|AI in the clinical setting||Jan '18||Curious||1|
Find what you want!
Search Oncology Forum Now
Copyright © 2018 Topix LLC